Highly Active Nanoparticles with Rapid Adsorption-Killing Mechanism for Combating Multidrug-Resistant Bacteria
Yunyun Xue,Zihao Zhao,Wenbo Huang,Ze-Lin Qiu,Xiao Li,Yu Zhao,Chuyao Wang,Ronglu Cui,Shuyang Shen,Hua Tian,Li-Feng Fang,Rong Zhou,Baoku Zhu
DOI: https://doi.org/10.2139/ssrn.4246345
2022-01-01
SSRN Electronic Journal
Abstract:Antibiotic abuse has rendered nosocomial infections associated with multidrug-resistant (MDR) bacteria one of the biggest hazards to public health in the 21st century. Fast, high-efficient, and non-resistant antimicrobial strategies are urgently required to prevent the increasing prevalence of MDR strains and the emergence of antibacterial resistance. In this work, a series of amphiphilic nanoengineered polyquaternium (ANPQ) have been designed and synthesized. Contrary to conventional antibiotics, RNA-sep analysis proved that the bacteria developed resistance to levofloxacin but not to ANPQ, even after 40 times of repeated administration. Surprisingly, in the MDR-pathogen-contaminated water model, all bacteria adsorbed to ANPQ-treated fabrics only after 10 seconds of exposure, and over 99.99% of the pathogens were killed within 30 seconds.Besides, ANPQ demonstrated strong adhesion to the fabric and exerted long-term durability (30 days) due to its water insolubility. In a mouse model of Methicillin-resistant Staphylococcus aureus wound infection, the fabrics treated with ANPQ could effectively kill pathogens in wound exudate and facilitate wound healing while remaining nontoxic. It is envisaged that ANPQ undoubtedly provide a promising candidate for fighting the rapid spread of MDR strains and the development of antibacterial resistance.Funding Information: Funding from New material Platform Project, Ministry of Industry and Information Technology of China (NO: TC190H3ZV-1), Fundamental Research Funds for the Central Universities (Grant No. 226-2022-00020), and Natural Science Foundation of Zhejiang Province, China (NO: LD22E030006) are highly acknowledged.Declaration of Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.Ethics Approval Statement: All animal experiments were performed under the Principles of Laboratory Animal Care (NIH Publication No. 86-23, revised 1985) and the guidelines of the Animal Care and Use Committee of Zhejiang University.